SEC Company Response from Q BioMed Inc. (QBIO) (CIK 0001596062) — May 6, 2020
Q BioMed Inc. (QBIO) (CIK 0001596062)
Date: May 6, 2020 · CIK: 0001596062 · Accession: 0001104659-20-057270
AI Filing Summary & Sentiment
File numbers found in text: 333-237872
Letter
Re: Q BioMed Inc. (the “Company)
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-237872 (the “Registration Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above, as most recently amended, be accelerated so that it will be declared effective at 9:00 am on Friday, May 8, 2020, or as soon thereafter as is practicable.
The Company acknowledges that:
● should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
Q BioMed Inc.
Show Raw Text
CORRESP
1
filename1.htm
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re:
Q BioMed Inc. (the “Company)
Registration Statement on Form S-1
File No. 333-237872 (the “Registration
Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred
to above, as most recently amended, be accelerated so that it will be declared effective at 9:00 am on Friday, May 8, 2020, or
as soon thereafter as is practicable.
The Company acknowledges that:
● should
the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
●
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
●
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
Q BioMed Inc.
By:
/s/ William Rosenstadt
Name:
William Rosenstadt
Title:
Chief Legal Officer